Overview
Actuated Medical's NeuralGlider(r) Precision Brain Access Platform has been scientifically validated by more than 40 preclinical neuroscience research groups worldwide and cited in over 44 peer-reviewed publications. Actuated is now optimizing NeuralGlider for clinical applications to improve access to deep brain targets while reducing tissue disruption in delicate brain structures. The company is partnering with organizations seeking to improve the insertion precision of neuromodulation systems, gene therapies, brain-computer interfaces, and other next-generation neurotechnologies.
More in Neurotechnology
Latest industry news
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Tether Evo Takes On One of BCI's Hardest Engineering Problems
2026-09-19 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →